Hepatitis D prevention: Difference between revisions
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) |
||
Line 7: | Line 7: | ||
==Prevention== | ==Prevention== | ||
In order to be infected with hepatitis D, a | In order to be infected with [[hepatitis D]], a patient must be previously [[infected]] with [[HBV]] ([[superinfection]]) or be infected by [[HBV]] at the same moment of [[infection]] with [[HDV]] ([[coinfection]]). The best prevention against [[hepatitis D]] is [[vaccination]] with [[hepatitis B vaccine]].<ref name=NIH>{{cite web | title = Hepatitis D prevention | url =http://www.niaid.nih.gov/topics/hepatitis/hepatitisd/Pages/prevention.aspx }}</ref> | ||
{{For|hepatitis B vaccine|Hepatitis B vaccine}} | {{For|hepatitis B vaccine|Hepatitis B vaccine}} | ||
Line 15: | Line 15: | ||
{{For|secondary prevention of hepatitis B|Hepatitis B secondary prevention}} | {{For|secondary prevention of hepatitis B|Hepatitis B secondary prevention}} | ||
Since a [[vaccine]] against hepatitis D is not available for patients who are already infected with [[HBV]], the best course of action to prevent superinfection in these patients is to avoid risk behaviors, such as: <ref name=NIH>{{cite web | title = Hepatitis D prevention | url =http://www.niaid.nih.gov/topics/hepatitis/hepatitisd/Pages/prevention.aspx }}</ref> | Since a [[vaccine]] against hepatitis D is not available for patients who are already infected with [[HBV]], the best course of action to prevent [[superinfection]] in these patients is to avoid risk behaviors, such as: <ref name=NIH>{{cite web | title = Hepatitis D prevention | url =http://www.niaid.nih.gov/topics/hepatitis/hepatitisd/Pages/prevention.aspx }}</ref> | ||
*Sex with an infected partner | *Sex with an infected partner | ||
Line 22: | Line 22: | ||
*Healthcare workers who deal with sharp objects, potentially with blood from infected patients should take extra caution | *Healthcare workers who deal with sharp objects, potentially with blood from infected patients should take extra caution | ||
It is essential to vaccinate the family members of patients who are [[infected]] with [[HBV]] and [[HDV]]. Despite the common [[parenteral]] transmission of [[HDV]], the virus has also been noted to be transmitted among family members, which justifies extraordinary precautions in these families.<ref name="pmid10207796">{{cite journal| author=Niro GA, Casey JL, Gravinese E, Garrubba M, Conoscitore P, Sagnelli E et al.| title=Intrafamilial transmission of hepatitis delta virus: molecular evidence. | journal=J Hepatol | year= 1999 | volume= 30 | issue= 4 | pages= 564-9 | pmid=10207796 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10207796 }} </ref> | |||
===HIV Infected Patients=== | ===HIV Infected Patients=== | ||
[[HIV]] infected persons may not develop protective [[immunity]] after receiving the [[hepatitis B vaccine]]. Hence, they remain at risk for infection with [[HBV]] and [[HDV]].<ref>Center for Substance Abuse Treatment. Screening for Infectious Diseases Among Substance Abusers. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 1993. (Treatment Improvement Protocol (TIP) Series, No. 6.) Chapter 15 - Viral Hepatitis D.</ref> | [[HIV]] infected persons may not develop protective [[immunity]] after receiving the [[hepatitis B vaccine]]. Hence, they remain at risk for infection with [[HBV]] and [[HDV]].<ref>Center for Substance Abuse Treatment. Screening for Infectious Diseases Among Substance Abusers. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 1993. (Treatment Improvement Protocol (TIP) Series, No. 6.) Chapter 15 - Viral Hepatitis D.</ref> |
Revision as of 21:05, 17 August 2014
Hepatitis D |
Diagnosis |
Treatment |
Hepatitis D prevention On the Web |
American Roentgen Ray Society Images of Hepatitis D prevention |
Risk calculators and risk factors for Hepatitis D prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2] Jolanta Marszalek, M.D. [3]
Overview
HDV infection requires the person to be co-infected with HBV, therefore, vaccination against hepatitis B also confers immunity against hepatitis D. Since a vaccine against hepatitis D for patients infected with HBV is not available, these individuals should prevent superinfection by avoiding risk behaviors, such as: contact with blood from infected individuals, and sharing of sharp objects.
Prevention
In order to be infected with hepatitis D, a patient must be previously infected with HBV (superinfection) or be infected by HBV at the same moment of infection with HDV (coinfection). The best prevention against hepatitis D is vaccination with hepatitis B vaccine.[1]
Since a vaccine against hepatitis D is not available for patients who are already infected with HBV, the best course of action to prevent superinfection in these patients is to avoid risk behaviors, such as: [1]
- Sex with an infected partner
- Contact with the blood of an infected person
- Sharing of needles, syringes, razors, or toothbrushes with an infected person
- Healthcare workers who deal with sharp objects, potentially with blood from infected patients should take extra caution
It is essential to vaccinate the family members of patients who are infected with HBV and HDV. Despite the common parenteral transmission of HDV, the virus has also been noted to be transmitted among family members, which justifies extraordinary precautions in these families.[2]
HIV Infected Patients
HIV infected persons may not develop protective immunity after receiving the hepatitis B vaccine. Hence, they remain at risk for infection with HBV and HDV.[3]
Pregnant Patients
Pregnant women should be screened for hepatitis B infection. If a woman is at risk for HBV infection, she should be vaccinated. The current recommendations of the American College of Pediatrics and the Centers for Disease Control and Prevention are that all infants be immunized against hepatitis B.[4]
References
- ↑ 1.0 1.1 "Hepatitis D prevention".
- ↑ Niro GA, Casey JL, Gravinese E, Garrubba M, Conoscitore P, Sagnelli E; et al. (1999). "Intrafamilial transmission of hepatitis delta virus: molecular evidence". J Hepatol. 30 (4): 564–9. PMID 10207796.
- ↑ Center for Substance Abuse Treatment. Screening for Infectious Diseases Among Substance Abusers. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 1993. (Treatment Improvement Protocol (TIP) Series, No. 6.) Chapter 15 - Viral Hepatitis D.
- ↑ Center for Substance Abuse Treatment. Screening for Infectious Diseases Among Substance Abusers. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 1993. (Treatment Improvement Protocol (TIP) Series, No. 6.) Chapter 15 - Viral Hepatitis D.